Singapore Medical Group Limited announced unaudited consolidated earnings results for the six months ended June 30, 2017. For the period, the company reported revenue was SGD 30,663,000 against SGD 19,473,000 a year ago. Profit before tax was SGD 4,542,000 against SGD 870,000 a year ago. Profit for the period attributable to owners of the company was SGD 4,012,000 against SGD 633,000 a year ago. Net cash flows generated from operating activities was SGD 3,964,000 against SGD 2,313,000 a year ago. Purchase of property, plant and equipment was SGD 689,000 against SGD 332,000 a year ago. Diluted earnings per share were 1.03 cents compared with 0.23 cents for the same period last year. The Group's revenue increased by 57.5% was mainly due to increase in revenue of Health Business segment by SGD 6.8 million or 42.3% from SGD 15.4 million for half year 2016 to SGD 21.9 million for half year of 2017 which mainly arose from the subsidiaries. EBITDA was SGD 5,909,000 against SGD 1,434,000 for the same period last year.